Xiuning Le, Associate Professor, Deputy Section Chief of Thoracic Medical Oncology at MD Anderson Cancer Center, shared Meimei Zheng on X, adding:
“Honored to share my second simultaneous publication at ESMO 2025, published in Annals of Oncology.
Our global leptomeningeal disease from NSCLC cohort study (2,052 patients) sets benchmark outcomes for this rare population and generates hypotheses for interventional studies.
Grateful to my mentors, colleagues, friends, and mentees for their collaboration and inspiration throughout this journey.
We will continue to work and move forward together.”
Quoting Meimei Zheng, Medical Oncologist at Guandong Lung Cancer Institute, post on X:
“Thrilled to share our global, multicenter study on leptomeningeal disease in NSCLC.
None of this is possible without the dedication of participating centers and shared commitment for the vulnerable patients!.”
Quoting Annals of Oncology‘s post on X:
“ESMO25 concomitant paper: results from the largest and most diverse international, multicenter, retrospective study on leptomeningeal metastases from NSCLC.”
Title: The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study
Authors: M.M. Zheng, Y. Xia, K. Pan, F. Sun, A.C. Tan, X.R. Dong, H.Y. Tu, L.B. Tang, Y.S. Li, K. Yin, M. Borgeaud, S. Singhal, E. Zhu, J. Zhang, M. Nilsson, J. Wu, D.L. Gibbons, H. Wakelee, J.W. Neal, J. Lee, A.A. Vaporciyan, W. Ringsurongkawong, H.T. Tran, R.Z. Zhang, T. Zhang, Q. Zhou, W.Z. Zhong, W. Li, Y.C. Zhang, J.W. Riess, A. Addeo, J.V. Heymach, N. Myall, D. Tan, Y.L. Wu, X. Le.
Read the full article on Annals of Oncology.
You can also read:
ESMO 2025 Day 1 Highlights Not to Miss
ESMO 2025 Day 2 Highlights Not to Miss
ESMO 2025 Day 3 Highlights Not to Miss
ESMO 2025 Day 4 Highlights Not to Miss
